That Happened!

New York - The finding of a study conducted by experts at the University of Texas M.D. Anderson Medical Center indicate that falling victim to breast cancer during pregnancy, a rare event in women under the age of 40, or within a year of pregnancy, does not have any bearing on your likelihood of successfully beating the disease. Over 650 women under the age of 35 suffering from breast cancer participated in the study, with 16 percent of participants afflicted with a rare ... Read More

New York - Risks associated with Combination Hormone Replacement Therapy (HRT) were first reported in a 2002 Woman's Health Initiative study. HRT is a commonly prescribed medical treatment that combines the hormones estrogen and progestin to treat symptoms of menopause such as hot flashes or vaginal dryness. In the initial study it was determined that a women receiving HRT had a 27 percent greater risk of breast cancer. A newly released analysis published in the New England Journal of Medicine found that a woman's ... Read More

New York - The theory that a combination of estrogen and progestin taken to relieve menopause can increase the risk of breast cancer, heart attacks and stroke appears to be right on target as numbers fell dramatically when women were warned about the prolonged use of these hormones. Federal statistics show about 210,000 women in the U.S. were diagnosed with breast cancer each year before 2002. The rate dropped suddenly after 2002 when the warning went out down to 190,000. The rates have ... Read More

A study conducted with 543 women who had breast cancer showed that women with breast cancer would rather opt for a double mastectomy to prevent cancer from growing in both breasts. It has not been easy for doctors to say who is most likely to have cancer occur in both breasts, when it is found in only one breast. Race and hormones have not been much help to try and determine this rate either. According to doctors there are three specific factors they ... Read More

New York - Hoping to begin clinical trials of a new vaccine to possibly prevent breast cancer from coming back, scientists from the University of Arkansas for Medical Sciences are now getting ready to start the trial process. This vaccine is not meant to replace current treatments for breast cancer, like chemotherapy or radiation, but to be used as an extra treatment to help it from coming back. This vaccine has been developed over the past 10 years based on what has been ... Read More

New York - A study that started around 2000 was stopped abruptly in 2002 because researchers conducting the study noticed a increased risk of breast cancer in patients undergoing hormone replacement therapy. Since the conclusion of that study, hormone replacement therapy has dropped almost 70% by postmenopausal women. The study has come to the conclusion that postmenopausal women who took progestin and estrogen for several years had a heightened risk of developing breast cancer. These findings were furthered when, during an amount ... Read More

New York - New Studies have concluded that typical menopausal hormone replacements do actually raise the risk for breast cancer. At the same time, studies have also shown the bone strengthening drug, Zometa can shrink breast tumors. Also the drugs Tykerb and Femara, together, have shown significant drops in the risk of breast cancer when used by some women. These findings are part of a wealth of studies on different drugs that women typically take for hormone replacement, osteoporosis treatments and other health issues ... Read More

New studies are finding that there may be ways to detect and possibly prevent relapse in breast cancer cases, scientists reported, as part of a presentation via teleconference on Friday. Scientists and researchers seemed very hopeful that some new revelations brought about by their research would aid in not only the treatment of certain breast cancers, but also the early detection of other types as well as the impact a breast cancer prevention medication may have on patients. At the annual San Antonio ... Read More

New York - Research continues to test run the many breakthrough breast cancer drugs after the success experienced with tamoxifen. Tamoxifen was found to reduce the risk of recurrent breast cancer in cases where women had receptor positive tumors. Several encouraging findings were announced and introduced this Thursday at a San Antonio Breast Cancer Symposium. The most promising of all the drugs was the osteoporosis drug, Zometa. This drug was found to shrink the appearance of tumors in the breast for patients who ... Read More

New York - Breast cancer is a horrible disease . A new scientific study is trying to answer the question; do breast cancer tumors ever go away on their own? Researchers want to know if breast cancers found with mammograms can disappear the same way that neuroblastoma which is a rare childhood cancer sometimes has. If breast cancers could disappear on their own then that would be an amazing medical discovery. Scientists say that it is possible for breast cancers to regress. However, ... Read More